<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25-vaccines-07-00074">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sagar</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Overbaugh</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity</article-title>
  <source>J. Virol.</source>
  <year>2006</year>
  <volume>80</volume>
  <fpage>9586</fpage>
  <lpage>9598</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00141-06</pub-id>
  <pub-id pub-id-type="pmid">16973562</pub-id>
 </element-citation>
</ref>
